Diseases, Conditions, Syndromes

EU approves first vaccine against common respiratory virus

The European Commission has followed the United States in approving the world's first vaccine for the Respiratory Syncytial Virus, to be used by adults aged 60 and over, its maker GlaxoSmithKline said Wednesday.

Autism spectrum disorders

Autistic adults report high rates of COVID-19 vaccination

As reported in 2021, autistic adults, adults with intellectual disability and adults with mental health diagnoses have multiple risk factors for COVID-19 infection, and more severe disease if contracted. Public health messaging ...

page 2 from 5